Mortality and readmissions after ventricular tachycardia ablation: An analysis of inpatient and outpatient state databases. Publication: Journal Article Brodeur, Peter G, Enrico G Ferro, Timothy G Maher, Jonathan W Waks, Andre D’Avila, ZhaoNian Zheng, Peter J Zimetbaum, et al. 2025. “Mortality and Readmissions After Ventricular Tachycardia Ablation: An Analysis of Inpatient and Outpatient State Databases.”. Heart Rhythm.
Use of Claims to Assess Outcomes and Treatment Effects in the Evolut Low Risk Trial. Publication: Journal Article Butala, Neel M, Christina Lalani, Archana Tale, Yang Song, Dhaval Kolte, Suzanne Baron, Jordan Strom, David J Cohen, and Robert W Yeh. 2025. “Use of Claims to Assess Outcomes and Treatment Effects in the Evolut Low Risk Trial.”. Circulation. Cardiovascular Interventions 18 (1): e014592.
Out-of-Pocket Savings Under the Inhaler Price Cap. Publication: Journal Article Mein, Stephen A, Ave K Kludze, William B Feldman, Archana P Tale, Jennifer P Stevens, and Rishi K Wadhera. 2025. “Out-of-Pocket Savings Under the Inhaler Price Cap.”. JAMA Internal Medicine 185 (3): 339-41.
Changes in Patient Care Experience After Private Equity Acquisition of US Hospitals. Publication: Journal Article Bhatla, Anjali, Victoria L Bartlett, Michael Liu, ZhaoNian Zheng, and Rishi K Wadhera. 2025. “Changes in Patient Care Experience After Private Equity Acquisition of US Hospitals.”. JAMA 333 (6): 490-97.
Delivering guideline-directed medical therapy for heart failure with reduced ejection fraction as an over-encapsulated polypill: rationale and protocol for the COMBO-HF-X pilot crossover randomised clinical trial. Publication: Journal Article DeJong, Colette, Matthew S Durstenfeld, Jonathan D Davis, Christina S Wang, Elise D Riley, Mark D Huffman, Matthew D Hickey, et al. 2025. “Delivering Guideline-Directed Medical Therapy for Heart Failure With Reduced Ejection Fraction As an Over-Encapsulated Polypill: Rationale and Protocol for the COMBO-HF-X Pilot Crossover Randomised Clinical Trial.”. BMJ Open 15 (3): e093663.
Direct-to-Physician Marketing and Uptake of Optimal Medical Therapy for Heart Failure With Reduced Ejection Fraction. Publication: Journal Article DeJong, Colette, Kosuke Inoue, Matthew S Durstenfeld, Anubha Agarwal, Justin C Chen, Chien-Wen Tseng, Adams Dudley, Priscilla Y Hsue, and Dhruv S Kazi. 2025. “Direct-to-Physician Marketing and Uptake of Optimal Medical Therapy For Heart Failure With Reduced Ejection Fraction.”. JACC. Heart Failure.
State of the Heart (and Brain) in 2025. Publication: Journal Article Kazi, Dhruv S. 2025. “State of the Heart (and Brain) in 2025.”. Circulation 151 (8): 515-17.
2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association. Publication: Journal Article Martin, Seth S, Aaron W Aday, Norrina B Allen, Zaid I Almarzooq, Cheryl A M Anderson, Pankaj Arora, Christy L Avery, et al. 2025. “2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.”. Circulation 151 (8): e41-e660.
Glucagon-Like Peptide 1 Receptor Agonists and Venous Thromboembolism in Type 2 Diabetes: A Target Trial Emulation. Publication: Journal Article Chiang, Cho Han, Junmin Song, Yu-Cheng Chang, Soravis Osataphan, Yu-Che Lee, Ko-Yun Chang, Kuan-Yu Chi, et al. 2025. “Glucagon-Like Peptide 1 Receptor Agonists and Venous Thromboembolism in Type 2 Diabetes: A Target Trial Emulation.”. Blood Advances.